Identification of two novel mouse nuclear proteins that bind selectively to a methylated c-Myc recognizing sequence
INTRODUCTION
The expression of mammalian genes often correlates with the methylation state of CpG sequences in the promoter region (7) . The promoter regions of the house keeping genes are undermethylated in all cells. In contrast, the tissue specific genes are usually methylated at the 5 position of cytidines in CpG sequences, except in the tissues in which they are expressed (2) . Usually, in vi/ro-methylated genes are inactive when transfected into cells (5) . During the cell differentiation, some of the tissue specific genes become demethylated in their promoter region. The inhibition of DNA methylation followed by DNA replication can passively demethylate the genes. A possibility of positive demethylation without DNA replication is also reported (4, 5) . In either mechanism, at least one of the proteins that participates in the demethylation step(s) must recognize either the hemi-or fully methylated CpG in a sequence specific manner. At present, several proteins that bind methylated CpG have been identified in vertebrates (6) (7) (8) (9) (10) (11) . MeCP-1 (6) and MeCP-2 (7) specifically bind to the methylated CpG. Both proteins, however, have no sequence specificity except the density of methylated CpG in the DNA. Although MDBP binds the methylated DNA in a sequence specific manner, its specificity is low: it also binds to sequences that are not methylated (8) (9) (10) . MDBP-2 binds the hormone responsive promoter region of vitellogenin gene of chick (11) . The binding region of MDBP-2 is demethylated prior to estrogeninduced transcription of the gene (12) . Partial sequencing of MDBP-2 revealed that the protein is a member of the histone HI family and that it has no sequence specificity in binding to methylated DNA (13) . MDBP-2, as well as MeCP-1 and MeCP-2, inhibits the in vitro transcription (13) (14) (15) (16) . So far, except for MDBP, no protein that recognizes methylated CpG in a sequence specific manner has been identified.
C-Myc is a nuclear proto-oncogene product that plays an important role in controlling proliferation and differentiation of the cells (17) ; however, the mechanism of c-Myc action remains unknown. C-Myc function as a transcription factor with its partner Max (18, 19) . It is a DNA-binding protein which recognizes a so-called E-box sequence containing a CpG sequence in the core (20, 21) . Two other transcription factors, upstream stimulatory factor (USF) (22) and transcription factor E3 (TFE3) (23) , the members of Myc family, also recognize the same E-box sequence as c-Myc binding motif that contains a CpG sequence in the center. USF and TFE3 recognize both unmethylated and methylated cytidine in the core CpG sequence in the c-Myc binding motif (21) . On the other hand, methylation of the CpG sequence in the motif inhibits the binding of c-Myc protein or its complex with Myn, a murine homologue of Max (21, 24) . This suggests that the function of c-Myc is regulated, at least in part, through the methylation state of the CpG. In the present study, we identified two novel proteins that recognize the methylated c-Myc binding motif in a sequence specific manner. The proteins that bind to the methylated c-Myc binding motif may provide a clue to understand the mechanism by which cMyc controls gene expression.
MATERIALS AND METHODS

Cells and cell culture
Mouse myogenic cell line C2C12 was kindly provided by Dr Nabeshima at National Institute of Neuroscience, Japan. Fibroblast cell lines C3H/1OT1/2 and 3T6-Swiss albino, and * To whom correspondence should be addressed PCC4 AG derived from testis were obtained from Japanese Cancer Research Resources Bank. Mouse erythroleukemia (MEL) strain 11A2 (25) was generously provided by Dr Watanabe at Tokyo University.
C2C12, C3H/10T1/2, 3T6-Swiss albino and PCC4 AG were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 100 units/ml of penicillin, and 100 /ig/ml of streptomycin. MEL was cultured in ES medium containing 2% fetal calf serum (25) .
C2C12 cells were cultured in plastic dishes coated with 0.1 % gelatin and differentiated into myotubes by changing the medium to Cosmedium (CosmoBio) (Ichikawa and Yoshimi, unpublished results). All the cells were maintained at 37°C under 5% CO2 atmosphere.
Preparation of nuclear extract and its fractionation by heparin-agarose chromatography
The nuclear extracts from different types of cell lines were prepared as described by Dignam et al. (26) , with a slight modification as follows. All the solutions contained 1 mM DTT. The high salt extract of isolated nuclei was centrifuged in a Beckman TL 100.2 rotor at 4°C for 10 min at 100,000 rpm. After dialyzing against 20 mM Hepes buffer (pH 7.4) containing 0.1 M KC1, 0.2 mM EDTA, 0.5 mM PMSF, 1 mM DTT and 20% (v/v) glycerol (buffer A), aliquots of extracts were frozen in liquid nitrogen and stored at -80°C until use.
The crude nuclear extract was loaded onto a heparin-agarose (Sigma) column, equilibrated with buffer B (50 mM Tris-HCl (pH 8.0), 0.2 mM EDTA, 1 mM DTT, 20% (v/v) glycerol) containing 0.01 M KC1. Protein bound to the column was eluted in a stepwise manner with 0.05, 0.1, 1.0 M KC1 in buffer B (27) . The eluate was dialyzed against buffer A and used for the binding studies.
Oligonucleotides
The oligonucleotides used in this study were synthesized with an Applied Biosystem model 381A DNA synthesizer using £-cyanoethyl-diisopropyl phosphoramidites;
where mC indicates 5-methyl deoxycytidine. The underlines indicate the E-box sequence (CANNTG) in each oligonucleotide.
As the E-box of the 'MyoD' did not have a CpG sequence in the core, two CpG out side the E-box were methylated. After synthesis, the oligonucleotides were purified by HPLC using C18-reverse phase cartridge, eluted with 6.75 -40% acetonitrile gradient in 0.1 M triethanolamine acetate (pH 7.2). The c-Myc recognition sequence ('myc') was taken from ref. 21 . The sequence 'MyoD' was the 5' (-276 249, nucleotide numbers from the initiation site) upstream region of the genomic sequence of MyoD gene (28) .
Equal moles (-35 pmoles) of complementary strands were phosphorylated with T4 polynucleotide kinase in 10 /J of 50 mM Tris-HCl (pH 8.0) buffer containing 10 mM MgCl 2 and 10 mM DTT, in the presence of [7- 32 P]ATP (Amersham International, > 185 TBq/mmol) or unlabeled ATP. To anneal the oligonucleotides, the mixture was 10-fold diluted with 50 mM NaCl in 10 mM Tris-HCl (pH 8.0) and 1 mM DTT, and then boiled for 10 min. Then the mixture was cooled slowly to room temperature in a water bath that was preheated to 65°C. The labeled and annealed oligonucleotides were passed through a Sephadex G-50 (fine) column, equilibrated with 10 mM Tris-HCl (pH 8.0) buffer containing 1 mM EDTA, to remove unincorporated radioactivities.
UV-light crosslinking of radiolabeled oligonucleotides to DNA binding protein Crude nuclear extract (~ 6 ng protein) or heparin fractionated extracts that were recovered from the same amount of nuclear extract (thus representing an equivalent amount) were preincubated at room temperature for 10 min in 20 /*1 of 12 mM Hepes (pH 7.4) buffer containing 1.5 mM Tris-HCl, 60-300 mM KC1, 1 mM EDTA, 0.36 mM PMSF, 0.6 mM DTT, 12% (v/v) glycerol, 1% (w/v) Triton X-100 and 3 ng poly(dI-dQ, with or without unlabeled oligonucleotides in double stranded A. form (50-fold molar excess). Radiolabeled oligonucleotide probe in double stranded form (2.0 ng, about 20,000 cpm/ng; see above) was added, and the mixture was incubated for additional 30 min at 30°C. The mixture on ice was then irradiated at a distance of 12 cm from UV germicidal bulbs (10Wx4). Each sample received an equal volume of 2 X sample buffer for SDS-PAGE (130 mM Tris-HCl (pH 6.8), 4% (w/v) SDS, 0.2% (v/v) 2-mercaptoethanol, 0.1 mg/ml bromophenol blue), and was boiled for 5 min. Subsequently, the samples were electrophoresed on a 12% polyacrylamide gel (29) . After the electrophoresis the gel was dried and subjected to autoradiography with a Kodak intensifying screen at -80°C.
Gel mobility shift assay
The samples were incubated as in the section for the 'UV-light crosslinking' assay. The mixtures, with or without UV-light irradiation, were electrophoresed on a 4% polyacrylamide gel (acrylamide:to-acrylamide=30:0.4, w/w) in 0.13XTBE buffer with the electrophoresis buffer of 0.13 XTBE at 15 V/cm at 4°C (30) . TBE (1X) consisted of 89mM Tris-base, 89mM boric acid and 25mM EDTA, pH 8.3. After the electrophoresis the gel was dried and subjected to autoradiography.
Other methods and reagents
Protein concentration was determined as described by Smith et al. (31) , with bovine serum albumin as a standard.
DMEM and ES media were purchased from Nissui Seiyaku (Tokyo, Japan), and fetal calf serum was from Gibco (Paisley, Scotland). Cosmedium was obtained from CosmoBio (Tokyo, Japan) and gelatin was from Iwaki Glass (Tokyo, Japan). The reagents for the synthesis of oligonucleotides were purchased from Applied Biosystems (Foster City, CA), except that 5-methyl deoxycytidine /3-cyanoethyl-diisopropyl phosphoramidite was from Pharmacia (Uppsala, Sweden). T4 polynucleotide kinase was obtained from Toyobo (Osaka, Japan) and poly(dl-dC) was from Pharmacia (Uppsala, Sweden). The other reagents used were guaranteed grade. 1 and 4)). The two proteins that were crosslinked to the methylated 'myc' were not seen when either fully methylated or unmethylated 'MyoD' were used as a probe (Fig. 1, panels  A and B, lanes 7 and 8) . Therefore, the two proteins bound not only methylation-specific, but also in a sequence-specific manner. 
RESULTS
Methylated DNA binding proteins that recognize c-Myc binding motif in a nuclear extract
To search for DNA binding proteins that distinguish methylated from unmethylated CpG in a sequence specific manner, we prepared two types of double stranded oligonucleotides with one or two methylated CpG sequences. One oligonucleotide corresponded to the c-Myc recognition site ('myc') reported by Prendergast et al. (24) and the other one corresponded to an unrelated control sequence, the upstream sequence of the mouse MyoD genomic gene that contained a MyoD binding site ('MyoD') (28) . The radiolabeled oligonucleotides, either unmethylated or methylated on both strands (=fully methylated) were mixed with a nuclear extract of C2C12, UV-light irradiated, and after SDS denaturation electrophoresed on a polyacrylamide gel. Two specific bands were crosslinked to the fully methylated 'myc' oligonucleotide (Fig. 1) A. We named the 42 and 63 kD proteins as MMBP-1 and -2, respectively, for methylated 'myc' binding protein.
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MMBP-1 was the major binding component in 60 mM KC1 (Fig. 1, panel A and Fig. 2 lane 5) , and MMBP-2 was the major binding component in 300 mM KC1 condition (Fig. 1, panel B and Fig. 2, lane 8) . Importandy, binding of both MMBP-1 and MMBP-2 to the fully methylated 'myc' was detected in 120 mM KC1 concentration (Fig. 2, lane 6) , which approximates physiological salt concentrations. Hence it is likely that both proteins can recognize the c-Myc binding motif in vivo.
Fractionation of nuclear extract on a heparin-agarose column
Nuclear extract from proliferating C2C12 cells was fractionated on a heparin-agarose column and used for the UV-crosslinking experiments (Fig. 3) . Most of the MMBP-1 as well as the MMBP-2 that bound preferentially to the fully methylated 'myc' were recovered in the flow-through fraction (0.01 M KC1). About 65% and 85% of the binding activities of MMBP-1 and MMBP-2, respectively, were recovered to this fraction, (Fig. 3 , panels A and B, lanes 2 and 4). As shown in Fig. 3 , lanes 5 -10, some bands other than the 42 and the 63 kD proteins that bound specifically to the fully methylated 'myc' were detected. Those proteins, however, were not found by UV-crosslinking when crude nuclear extract was used (see Figs 1 and 2) , and therefore, were not further pursued in this study.
Gel mobility shift assay of MMBP-1 and MMBP-2
We tried to detect MMBP-1 and MMBP-2 bands by gel mobility shift assay. When the radiolabeled fully methylated 'myc' and crude nuclear extract of C2C12 or the flow-through fraction from a heparin-agarose column were incubated, two shifted bands were detected (Fig. 4, panel A, lanes 5 -8 and panel B, lanes 2, 4, 5mC --+ +-++ --+ +- 6 and 8). The appearance of the bands depended on the methylation of 'myc' and on the salt concentration in the incubation buffer. The band with low mobility increased its intensity as the KC1 concentration was raised from 60mM to 300mM. And, the high mobility band was detected when the mixture was incubated in 60mM or 120mM KC1 (panel A, lanes 5 and 6, and panel B, lanes 2 and 4), and was not seen when incubated in 300mM KC1 (panels A and B, lane 8). About 100% and 60% of the activities of the low and high mobility bands were recovered to the flow-through fraction, respectively. Gel mobility shift assay after UV-light crosslinking without SDS-denaturation again demonstrated two shifted bands (panel B, lanes 9-16 and panel C). The crosslinked bands with low and high mobilities increased and decreased their intensities as the KC1 concentration was raised from 60mM to 300mM, respectively (panel C, lanes 2, 4, 6 and 8), indicating that the bands are MMBP-1 and MMBP-2. The mobility of each UV-crosslinked band was identical to that of the low or high mobility band appeared without UV-light irradiation (panel A, lanes 5 -8 and panel B, lanes 2, 4, 6 and 8). From the property of the mobilities, together with the properties that the binding activities depended on the salt concentration and were recovered to the flow-through fraction from a heparin-agarose column, we concluded that the two bands seen in the gel mobility shift assay were MMBP-1 and MMBP-2.
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The binding specificity of MMBP-1 and MMBP-2 As we would expect for sequence-specific binding, excess of nonlabeled fully methylated 'myc' ( a strand specific methylation in the 'myc' sequence. In contrast to MMBP-1, either of the two different hemimethylated 'myc' sequences bound equally well to MMBP-2, albeit at an about 2-fold reduced level of fully methylated 'myc' (Fig. 6 lanes 6-8) .
Cell type specificity of the binding activities of the two proteins Figure 7 (panels A and B) shows cell type specific expressions of the binding activities of the proteins to methylated 'myc'. MMBP-1 was detected in specific cells only, e.g. in fibroblasts (C3H/1OT1/2 and 3T6-Swiss albino) and myogenic cells (C2C12) both in proliferating and differentiated stages, but not in cell lines derived from testis (PCC4 AG) and from blood cells (MEL) (Fig. 7, panel A) . In contrast, MMBP-2 was detected in all the cell lines tested (Fig. 7, panel B) . Thus, MMBP-2 seems to be ubiquitously expressed.
DISCUSSION
The promoter regions are demethylated in many of the tissue (cell) specific genes when they are active. We hypothesized that specific proteins exist that recognize these promoter sequences in i) methylation dependent and ii) sequence specific manners. Some of these proteins may participate directly or indirectly in the demethylation system. As a first step to test this hypothesis, we searched for the proteins that recognize the methylated CpG in a specific sequence. We found two novel proteins that bound the c-Myc binding motif ('myc') containing a pair of methylated CpG. The two proteins, MMBP-1 and MMBP-2, recognized the identical 'myc' sequence under physiological salt concentration. The binding activity of MMBP-1 detected in gel mobility shift assay was lower than that of UV-crosslinked one (compare Fig. 4, panel B, lanes 1-8 and 9-16 ). This may be because the labeled oligonucleotide was dissociated from MMBP-1 during the electrophoresis. This may happen when MMBP-1 binds to and dissociates from the methylated 'myc' very quickly even though MMBP-1 binds to the oligonucleotide in high affinity in the binding buffer, or when MMBP-l binds weakly to the methylated 'myc'. Granting MMBP-1 binds weakly to the motif, it does not mean that MMBP-1 is unimportant in vivo. These two proteins are different from the known methylation-dependent binding proteins, such as MeCP-1 (6, 14, 15) , MeCP-2 (7,16), MDBP (8-10) and MDBP-2 (11, 13) , in several points. First, MMBP-1 and MMBP-2 have different molecular weight than the known proteins. The reported molecular weights of MeCP-1, MeCP-2, MDBP and MDBP-2 are 120, 84, 80-120 (estimated from the value S2o, w = 6.1) and 21K, respectively (6) (7) (8) 13) . Second, the binding sequence, 'myc', used in the present study is different from the consensus sequences recognized by those four proteins (6, 11, 13) . Third, in contrast to the MeCP and MDBP-2 proteins, which have no sequence specificity in binding (7, 13, 16) , both of the two proteins described here bound in a sequence specific manner, since the proteins could not recognize the methylated 'MyoD' motif. From those results we concluded that the methylation dependent binding proteins, MMBP-1 and MMBP-2, are novel proteins.
C-Myc, which is believed to be linked to proliferation and differentiation (6) , is a DNA binding protein and functions as a transcription factor (17) (18) (19) (20) (21) . In the present study we could not detect the binding activity of c-Myc protein to the 'myc' oligonucleotide. The expression levels of endogenous c-Myc may be too low for the detection. At present, two other transcription factors, USF and TFE3 are known to recognize the identical Ebox sequence that contains a CpG in the core (22, 23) . USF and TFE3, however, bind both methylated and unmethylated c-Myc binding motif (21) , while c-Myc binds only to the unmethylated sequence (21, 24) . Therefore, USF or TFE3 cannot be identical to the two methylation dependent binding proteins described in this study, which bound specifically to the fully methylated or hemimethylated motif. The binding of the two proteins to the methylated c-Myc binding motif may facilitate or prevent the methylated site from demethylation. We therefore propose that these two proteins may control the function of c-Myc protein by regulating its binding to DNA through stabilizing or unstabilizing the methylated form. Further characterization of the two proteins may hopefully shed light on the function and regulation of the c-Myc protein.
